Comparar métodos
Revisa los métodos seleccionados uno junto a otro; las filas que difieren aparecen resaltadas.
| Cuestionario de Impacto de la Fibromialgia× | EORTC QLQ-C30× | |
|---|---|---|
| Campo | Resultados en salud | Resultados en salud |
| Familia | Process / pipeline | Process / pipeline |
| Año de origen≠ | 1991 | 1993 |
| Autor original≠ | Cynthia S. Burckhardt et al. | Nico Aaronson et al. |
| Tipo≠ | Self-report symptom and functional impairment questionnaire | Self-report quality of life questionnaire |
| Fuente seminal≠ | Burckhardt, C. S., Clark, S. R., & Bennett, R. M. (1991). The Fibromyalgia Impact Questionnaire: Development and validation. The Journal of Rheumatic Diseases, 18(5), 728-735. link ↗ | Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376. DOI ↗ |
| Alias | FIQ, Fibromyalgia Impact, Fibromyalgia Questionnaire | QLQ-C30, EORTC QLQ-C30, Cancer Quality of Life Scale |
| Relacionados≠ | 4 | 5 |
| Resumen≠ | The FIQ is the most widely used patient-reported outcome measure for fibromyalgia disease burden. Developed by Cynthia Burckhardt and colleagues in 1991, this 10-item questionnaire quantifies how fibromyalgia affects physical function, work capacity, depression, anxiety, sleep, pain, and fatigue. The revised version (FIQR, 21 items) offers enhanced psychometric properties and is the current standard in fibromyalgia clinical trials and practice. | The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care. |
| ScholarGateConjunto de datos ↗ |
|
|